Researchers in the UK are testing a new drug that they believe may
The drug was developed by university scientists andby AstraZeneca. The Medicines and Healthcare Agency is expected to approve the drug for use in the country as early as next week.
The research team hopes that duringtest cocktail of antibodies protects against COVID-19 for a period of 6 to 12 months. Participants in the trial will receive it in two doses, which they must take in sequence.
A new strain of coronavirus has emerged in Africa
Researchers expect the drug toavailable already in March or April 2021. The study involves scientists from UCLH, as well as several UK hospitals. University College Hospital became the first place in the world where patients were recruited into a randomized controlled trial and received an injection of a drug or placebo.
“So far we have injected 10 participants -employees, students and others - who have been exposed to the virus at home, in a medical facility, or in student halls. We and my colleagues will closely follow the participants who decide to help us with the experiment, ”the researchers noted.
Read also
See the ISS flying between Jupiter and Saturn
The brightest blazar shines on the Earth. What does this mean for the planet?
"Study failed": Sputnik V testers will no longer receive placebo